SCHEMBL8779101

SCHEMBL8779101

O=C1c2cc(Br)ccc2CCC12CCCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
PARP10 Q53GL7 2/20 0.46
PARP1 P09874 1/20 0.46
SIGMAR1 Q99720 7/20 0.43
HTR2A P28223 5/20 0.43
HTR2C P28335 5/20 0.43
HTR2B P41595 5/20 0.43
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
TDP2 O95551 1/20 0.39
KDM1A O60341 1/20 0.38
DRD2 P14416 5/20 0.38
CMA1 P23946 1/20 0.38
AHR P35869 1/20 0.38
S100A4 P26447 1/20 0.37
TYMS P04818 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16622009 0.93 TDP1 (0.53) TDP1L3MBTL1PARP10PARP1SIGMAR1
SCHEMBL16622013 0.90 TDP1 (0.50) TDP1L3MBTL1PARP10PARP1SIGMAR1
SCHEMBL7885437 0.89 TDP1 (0.61) TDP1L3MBTL1PARP10PARP1SIGMAR1
SCHEMBL449187 0.86 TDP1 (0.46) TDP1L3MBTL1PARP10PARP1SIGMAR1
SCHEMBL16622016 0.84 TDP1 (0.45) TDP1L3MBTL1PARP10PARP1SIGMAR1
SCHEMBL9948561 0.81 TDP1 (0.44) TDP1L3MBTL1PARP10PARP1CA1
SCHEMBL7887145 0.81 BACE1 (0.46) TDP1L3MBTL1
SCHEMBL8778992 0.80 TDP1 (0.39) TDP1L3MBTL1PARP10PARP1SIGMAR1
SCHEMBL8779154 0.80 PARP1 (0.46) PARP10PARP1SIGMAR1HTR2AHTR2C
SCHEMBL22892512 0.80 SIGMAR1 (0.46) PARP10PARP1SIGMAR1HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606661-B1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists HOFFMANN LA ROCHE (CH) 1997-03-12 EP disclosed
US-5385947-A For prevention of nerve damage due to reduction of blood or oxygen supplies HOFFMANN-LA ROCHE INC. (US) 1995-01-31 US disclosed
EP-0606661-A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists F. HOFFMANN-LA ROCHE AG (CH) 1994-07-20 EP disclosed